Chunk #7 — Method — Validation of a Rare CNV on 15q13.3

Source

Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.

Embedded

yes

Text

A total of 41 subjects were included in the validation study using quantitative real-time polymerase chain reaction analysis, including eight ADHD 15q13.3 duplication carriers (ADHD carriers) and their family members, eight randomly selected ADHD subjects without duplications (ADHD noncarriers), six comparison subjects with the duplication (control carriers), and four random comparison subjects (non-ADHD). The characteristics of each subject are summarized in Table S2 in the online data supplement, and procedures are explained in Table S3.